KZIA logo

KZIA Stock Overview

Profile

Full Name:

Kazia Therapeutics Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

January 6, 1999

Indexes:

Not included

Website:

http://www.kaziatherapeutics.com

Description:

Kazia Therapeutics Limited is a biotechnology company focused on developing innovative cancer treatments. They work on new drugs to improve patient outcomes, particularly in brain cancer. Their research aims to provide effective therapies that can help patients live longer and healthier lives.

Key Details

Price

$0.84

Market Cap

$3.66 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.51 M

Annual EPS

-$6.66(+12.00% YoY)

PE Ratio

-

Annual ROE

-2741.04%

Annual Debt To Equity

-0.06

Beta

2.75

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Mar 27, 2024

Recent annual earnings:

Aug 29, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 28, 2024

Analyst ratings

Recent major analysts updates

Feb 6, 25 Maxim Group
Buy
Jul 12, 24 HC Wainwright & Co.
Buy
Apr 11, 23 HC Wainwright & Co.
Buy
Aug 2, 22 Maxim Group
Hold
Aug 2, 22 HC Wainwright & Co.
Neutral
Oct 14, 21 Maxim Group
Buy
Jan 5, 21 HC Wainwright & Co.
Buy

Screeners with KZIA included

Growing Shares Outstanding
Stocks with high beta
Stocks below SMA 200
Earnings this week
Healthcare sector
All stocks
Stocks with low RSI
Biotechnology industry
Small cap stocks
Earnings today

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.84
KZIA price is $0.84

Price All-time High

$2057.27
KZIA price is currently -99.96% below its historical high of $2057.27

Price Analysts Target

-
KZIA price consensus analysts' forecast is unknown

Price Today Change

+2.41%
KZIA price is up +2.41% today

Price YTD Change

-54.84%
KZIA price is down -54.84% since January 1st

Price 3-Year Change

-98.75%
KZIA price is down -98.75% over the past 3 years

Market cap

Market Cap

$3.66 M
KZIA market capitalization is $3.66 million

Market Cap 3-Year Change

-95.88%
KZIA market capitalization is down -95.88% over the past 3 years

Market Cap All-time High

$196.68 M
KZIA market capitalization is currently -98.14% below its historical high of $196.68 million

Market Cap Sector Rank

10.11%
KZIA market capitalization is higher than 10.11% of companies in Healthcare sector

Technical

Beta

2.75
KZIA beta is 2.75

200-day SMA

$3.45
KZIA price is currently -75.65% below its 200-day simple moving average

14-day RSI

29.91
KZIA 14-day relative strength index is 29.91

30-day Relative Volume

0.75
KZIA 30-day relative volume is 0.75

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$1.51 M
KZIA annual revenue is $1.51 million

Annual Revenue Analysts Estimate

-
KZIA annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
KZIA annual revenue 1-year change is unknown

Annual Revenue Sector Rank

14.71%
KZIA annual revenue is higher than 14.71% of companies in Healthcare sector

Profit

Annual Gross Profit

-
KZIA annual gross profit value is unknown

Annual Gross Margin

-
KZIA annual gross profit margin value is unknown

Annual Operating Profit

-$18.77 M
KZIA annual operating income is -$18.77 million

Annual Operating Margin

-1240.69%
KZIA annual operating profit margin is -1240.69%

Annual Net Income

-$17.55 M
KZIA annual net profit is -$17.55 million

Annual Net Margin

-1160.23%
KZIA annual net profit margin is -1160.23%

EPS

Annual EPS

-$6.66
KZIA annual earnings per share is -$6.66

Annual EPS Analysts Estimate

-$0.05
KZIA annual earnings per share is currently >+9900.00% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+12%
KZIA annual earnings per share is up +12% year-on-year

Annual EPS Sector Rank

18.44%
KZIA annual earnings per share is higher than 18.44% of companies in Healthcare sector

ROA & ROE

Annual ROA

-106.34%
KZIA annual return on assets is -106.34%

Annual ROE

-2741.04%
KZIA annual return on equity is -2741.04%

EBIT & EBITDA

Annual EBIT

-$18.77 M
KZIA annual earnings before interest & taxes is -$18.77 million

Annual EBITDA

-$17.55 M
KZIA annual EBITDA is -$17.55 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
KZIA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
KZIA price to earnings ratio is unknown

PB Ratio

PB Ratio

-0.55
KZIA price to book ratio is -0.55

PB Ratio Sector Rank

11.07%
KZIA price to book ratio is higher than 11.07% of companies in Healthcare sector

PS Ratio

PS Ratio

-
KZIA price to sales ratio value is unknown

PS Ratio Sector Rank

-
KZIA price to sales ratio is unknown

Enterprise value

Enterprise Value

$2.97 M
KZIA enterprise value is $2.97 million

Enterprise Value Sector Rank

15.66%
KZIA enterprise value is higher than 15.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
KZIA EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
KZIA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.24
KZIA annual current ratio is 0.24

Annual Quick Ratio

-
KZIA annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-0.06
KZIA annual debt to equity ratio is -0.06

Annual Interest Coverage Ratio

-
KZIA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
KZIA piotroski f-score value is unknown

Altman Z-Score

-12.64
KZIA altman z-score is -12.64

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$14.43 M
KZIA annual total assets is $14.43 million

Annual Non Current Assets

$10.32 M
KZIA annual long term assets is $10.32 million

Annual Current Assets

$4.11 M
KZIA annual total current assets is $4.11 million

Annual Cash & Cash Equivalents

$1.11 M
KZIA annual cash & cash equivalents is $1.11 million

Equity

Annual Book Value

-$6.70 M
KZIA annual book value is -$6.70 million

Annual Working Capital

-$13.14 M
KZIA annual working capital is -$13.14 million

Liabilities

Annual Total Liabilities

$21.12 M
KZIA annual total liabilities is $21.12 million

Annual Total Long Term Liabilities

$3.88 M
KZIA annual total long term liabilities is $3.88 million

Annual Current Liabilities

$17.24 M
KZIA annual total current liabilities is $17.24 million

Annual Accounts Payable

$3.04 M
KZIA annual accounts payable is $3.04 million

Debt

Annual Total Debt

$423.80 K
KZIA annual total debt is $423.80 thousand

Annual Total Debt 1-Year Change

-64.35%
KZIA annual total debt is down -64.35% year-on-year

Annual Long Term Debt

-
KZIA annual long term debt value is unknown

Annual Short Term Debt

$423.80 K
KZIA annual short term debt is $423.80 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$20.29 M
KZIA annual total expenses is $20.29 million

Annual Operating Expenses

$20.29 M
KZIA annual total operating expenses is $20.29 million

Annual Cost Of Goods Sold

-
KZIA annual cost of goods sold value is unknown

Annual SGA

$8.89 M
KZIA annual SGA is $8.89 million

Annual D&A

$1.23 M
KZIA annual depreciation & amortization is $1.23 million

Annual Interest Expense

-
KZIA annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$6.28 M
KZIA annual cash flow from operations is -$6.28 million

Annual CFO 1-Year Change

+38.4%
KZIA annual cash flow from operations is up +38.4% year-on-year

Annual CFI

$0.00
KZIA annual cash flow from investing activities is $0.00

Annual CFI 1-Year Change

0%
KZIA {parameterFullLabel} has remained unchanged year-on-year

Annual CFF

$3.92 M
KZIA annual cash flow from financing activities is $3.92 million

Annual CFF 1-Year Change

-55.04%
KZIA annual cash flow from financing activities is down -55.04% year-on-year

Free CashFlow

Annual FCF

-$6.28 M
KZIA annual free cash flow is -$6.28 million

Annual FCF 1-Year Change

+38.4%
KZIA annual free cash flow is up +38.4% year-on-year

CAPEX

Annual CAPEX

-
KZIA annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
KZIA annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

NCNA logo
NuCana (NCNA)
GLMD logo
Galmed Pharmaceuticals (GLMD)
CNSP logo
CNS Pharmaceuticals (CNSP)
ALLR logo
Allarity Therapeutics (ALLR)
EYEN logo
Eyenovia (EYEN)
INM logo
InMed Pharmaceuticals (INM)
SNPX logo
Synaptogenix (SNPX)
HSCS logo
Heart Test Laboratories (HSCS)
ELAB logo
Elevai Labs (ELAB)

FAQ

  • What is the ticker symbol for Kazia Therapeutics Limited?
  • Does Kazia Therapeutics Limited pay dividends?
  • What sector is Kazia Therapeutics Limited in?
  • What industry is Kazia Therapeutics Limited in?
  • What country is Kazia Therapeutics Limited based in?
  • When did Kazia Therapeutics Limited go public?
  • Is Kazia Therapeutics Limited in the S&P 500?
  • Is Kazia Therapeutics Limited in the NASDAQ 100?
  • Is Kazia Therapeutics Limited in the Dow Jones?
  • When was Kazia Therapeutics Limited's last earnings report?
  • When does Kazia Therapeutics Limited report earnings?

What is the ticker symbol for Kazia Therapeutics Limited?

The ticker symbol for Kazia Therapeutics Limited is NASDAQ:KZIA

Does Kazia Therapeutics Limited pay dividends?

No, Kazia Therapeutics Limited does not pay dividends

What sector is Kazia Therapeutics Limited in?

Kazia Therapeutics Limited is in the Healthcare sector

What industry is Kazia Therapeutics Limited in?

Kazia Therapeutics Limited is in the Biotechnology industry

What country is Kazia Therapeutics Limited based in?

Kazia Therapeutics Limited is headquartered in Australia

When did Kazia Therapeutics Limited go public?

Kazia Therapeutics Limited's initial public offering (IPO) was on January 6, 1999

Is Kazia Therapeutics Limited in the S&P 500?

No, Kazia Therapeutics Limited is not included in the S&P 500 index

Is Kazia Therapeutics Limited in the NASDAQ 100?

No, Kazia Therapeutics Limited is not included in the NASDAQ 100 index

Is Kazia Therapeutics Limited in the Dow Jones?

No, Kazia Therapeutics Limited is not included in the Dow Jones index

When was Kazia Therapeutics Limited's last earnings report?

Kazia Therapeutics Limited's most recent earnings report was on Mar 27, 2024

When does Kazia Therapeutics Limited report earnings?

The next expected earnings date for Kazia Therapeutics Limited is Feb 28, 2025